Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 3

    Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules

    Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules

    Medical Dialogues Bureau10 April 2020 12:01 PM IST
    Butalbital, Acetaminophen and Caffeine Capsules are used for the relief of the symptom complex of tension headache.
    Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

    Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

    Medical Dialogues Bureau10 April 2020 10:00 AM IST
    Mumbai: Cipla Limited has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate...
    No need to panic over availability of PPE: Health ministry

    No need to panic over availability of PPE: Health ministry

    Medical Dialogues Bureau10 April 2020 9:00 AM IST
    New Delhi: The Union health ministry on Thursday said there is no need to panic over the availability of COVID-19 personal protective equipment (PPE),...
    US pharmacies authorized to test for COVID-19

    US pharmacies authorized to test for COVID-19

    Medical Dialogues Bureau10 April 2020 9:00 AM IST
    Washington: The US authorized pharmacies on Wednesday to carry out tests for the coronavirus, including newly developed antibody tests that detect...
    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Medical Dialogues Bureau9 April 2020 1:36 PM IST
    Hyderabad: A class-action suit has been filed against some drug manufacturers, including Aurobindo Pharma and Emcure Pharmaceuticals, in a USA court...
    Zydus gets USFDA final approval for Imatinib Mesylate Tablets

    Zydus gets USFDA final approval for Imatinib Mesylate Tablets

    Medical Dialogues Bureau9 April 2020 1:01 PM IST
    Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Imatinib Mesylate Tablets, 100 mg and 400 mg. (US RLD: Gleevec®...
    With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

    With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

    Medical Dialogues Bureau9 April 2020 12:30 PM IST
    New Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative...
    Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT

    Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT

    Medical Dialogues Bureau9 April 2020 10:00 AM IST
    New York: President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to...
    Swasth Ke Sipahi delivering essential services and medicines at doorstep of patients and elderly under PMBJP

    Swasth Ke Sipahi delivering essential services and medicines at doorstep of patients and elderly under PMBJP

    Medical Dialogues Bureau9 April 2020 9:00 AM IST
    Delhi: Pharmacists, popularly known as "Swasth Ke Sipahi", of Pradhan Mantri Jan Aushadhi Kendra, are delivering essential services and medicines at...
    Merck KEYTRUDA gets USFDA priority review for its Second Application

    Merck KEYTRUDA gets USFDA priority review for its Second Application

    Medical Dialogues Bureau9 April 2020 9:00 AM IST
    Kenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted and...
    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Medical Dialogues Bureau8 April 2020 2:15 PM IST
    Mysuru: The drug-making plant of pharma major Jubilant Life Sciences at Nanjangud near here has been shut down after it was suspected to have been...
    Zydus gets USFDA final approval for Perphenazine Tablets USP

    Zydus gets USFDA final approval for Perphenazine Tablets USP

    Medical Dialogues Bureau8 April 2020 12:56 PM IST
    Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg. (US RLD: Trilafon®...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok